GENESIS Biomed
VC Fund
Barcelona, Spain
GENESIS Biomed is a VC fund in Barcelona focused on Medical and Health Care. Life sciences R&D, consulting and investment
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries GENESIS Biomed invests in
Stages GENESIS Biomed invests in
Countries GENESIS Biomed invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $121k–$681k
Investment Focus
Industry
- Medical 3 (75%)
- Health Care 2 (50%)
- Pharmaceutical 2 (50%)
- Biopharma 1 (25%)
- Life Science 1 (25%)
Stage
- Seed 2 (50%)
- Pre-Seed 1 (25%)
- Venture - Series Unknown 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ownmed Innovation
|
Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence. | $681.1K / Seed / May 23, 2024 | |
Affirma Biotech
|
Affirma Biotech is a developer of host-directed drugs as broad-spectrum treatments for chronic and severe infectious diseases. The company utilizes host-directed therapy strategies to interfere with host cell factors that are required by a pathogen for replication or persistence. The company engages in the discovery and development of newanti-infective drugs via immunomodulation. | $1.9M / Venture - Series Unknown / Feb 01, 2024 | |
Thytech
|
Thytech is a health tech company. | $380.7K / Pre-Seed / Apr 08, 2022 | |
Telara Pharma
|
Telara Pharma designs a drug capable in the treatment and prevention of acute kidney injury. | $121.4K / Seed / May 11, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does GENESIS Biomed invest in?
GENESIS Biomed invests primarily in Medical, Health Care and Pharmaceutical startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is GENESIS Biomed's check size?
GENESIS Biomed typically joins rounds of $121k–$681k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds GENESIS Biomed participates in.
How do I contact GENESIS Biomed?
Public channels for GENESIS Biomed include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at GENESIS Biomed?
The team at GENESIS Biomed includes Josep Lluís Falcó (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
